FN1 and colorectal carcinoma: Although the highest levels were observed in later stage CRC (stage III-IV), the serum levels of anti-Fn-IgA and anti-Fn-IgG of CRC patients in stage I-II were not significantly difference than stage III-IV (P = 0.890; P = 0.200).